G1 Therapeutics to Provide Second Quarter 2020 Corporate and Financial Update on August 5, 2020

NEXT STORY
Myriad Launches Proprietary AMPLIFY™ Technology, Further Increasing the Performance of its Prequel™ NIPS Test
PREV STORY
ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

IBA and Proton International sign contract for Proteus®ONE Proton Therapy solution in Arkansas, US

author_avatar
NASDAQ Market News

Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine

author_avatar
NASDAQ Market News

Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights

author_avatar
NASDAQ Market News